The acronym ESKAPE includes six nosocomial pathogens that exhibit multidrug resistance
and virulence: Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae …

The massive consumption of antibiotics in the ICU is responsible for substantial ecological
side effects that promote the dissemination of multidrug-resistant bacteria (MDRB) in this …

Carbapenem-resistant Acinetobacter baumannii (CRAB) has emerged as a major global
pathogen with limited treatment options. No new antibiotic chemical class with activity …

Antibiotic resistance is one of the biggest challenges for the clinical sector and industry,
environment and societal development. One of the most important pathogens responsible …

Background The literature on the epidemiology, mortality and treatment of pandrug-resistant
(PDR) Gram-negative bacteria (GNB) is scarce, scattered and controversial. Objectives To …

Acinetobacter baumannii is increasingly associated with various epidemics, representing a
serious concern due to the broad level of antimicrobial resistance and clinical …

Background Acinetobacter calcoaceticus–A. baumannii (Acb) complex and
Stenotrophomonas maltophilia represent frequent causes of hospital-acquired infections …

Acinetobacter baumannii is a ubiquitous, Gram-negative, nonflagellated coccobacillus
bacterium commonly isolated from the environment. In human medicine, this opportunistic …

The peptide antibiotic albicidin is a DNA topoisomerase inhibitor with low-nanomolar
bactericidal activity towards fluoroquinolone-resistant Gram-negative pathogens. However …

Acinetobacter baumannii is a leading cause of nosocomial infections that severely threaten
public health. The formidable adaptability and resistance of this opportunistic pathogen have …